Robert W. Baird Forecasts Strong Price Appreciation for Xylem (NYSE:XYL) Stock

Xylem (NYSE:XYLGet Free Report) had its price objective hoisted by stock analysts at Robert W. Baird from $139.00 to $148.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the industrial products company’s stock. Robert W. Baird’s price target indicates a potential upside of 12.55% from the stock’s previous close.

Several other brokerages have also weighed in on XYL. Citigroup lowered their target price on shares of Xylem from $148.00 to $147.00 and set a “buy” rating for the company in a research note on Monday, January 13th. TD Cowen lowered their price target on Xylem from $138.00 to $125.00 and set a “hold” rating for the company in a research report on Wednesday, November 6th. Wolfe Research reiterated a “peer perform” rating on shares of Xylem in a report on Thursday, December 12th. Royal Bank of Canada dropped their target price on Xylem from $163.00 to $162.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Finally, Stifel Nicolaus reduced their price target on shares of Xylem from $166.00 to $150.00 and set a “buy” rating on the stock in a research report on Friday, January 24th. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $149.90.

Get Our Latest Report on Xylem

Xylem Stock Performance

Xylem stock opened at $131.50 on Wednesday. The firm has a 50 day simple moving average of $120.86 and a 200-day simple moving average of $127.61. The stock has a market cap of $31.95 billion, a price-to-earnings ratio of 38.45, a price-to-earnings-growth ratio of 2.11 and a beta of 1.07. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.96 and a quick ratio of 1.42. Xylem has a 1-year low of $113.26 and a 1-year high of $146.08.

Xylem (NYSE:XYLGet Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The industrial products company reported $1.18 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.06. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The company had revenue of $2.30 billion during the quarter, compared to analyst estimates of $2.18 billion. During the same period in the prior year, the business posted $0.99 earnings per share. The firm’s revenue for the quarter was up 8.6% compared to the same quarter last year. On average, analysts expect that Xylem will post 4.22 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the business. State Street Corp lifted its stake in Xylem by 1.9% during the third quarter. State Street Corp now owns 10,329,494 shares of the industrial products company’s stock worth $1,394,792,000 after purchasing an additional 189,820 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Xylem by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 5,668,755 shares of the industrial products company’s stock valued at $762,804,000 after buying an additional 54,877 shares in the last quarter. Impax Asset Management Group plc grew its position in shares of Xylem by 231.5% in the 4th quarter. Impax Asset Management Group plc now owns 5,561,661 shares of the industrial products company’s stock valued at $644,039,000 after buying an additional 3,883,845 shares during the last quarter. Swedbank AB raised its stake in Xylem by 23.1% during the 4th quarter. Swedbank AB now owns 3,683,201 shares of the industrial products company’s stock worth $427,325,000 after acquiring an additional 691,618 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Xylem by 1.0% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,449,307 shares of the industrial products company’s stock valued at $465,760,000 after acquiring an additional 32,645 shares during the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.

About Xylem

(Get Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Articles

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.